Victory Capital Management
PALI icon

Victory Capital Management’s Palisade Bio PALI Stock Holding History

Victory Capital Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.8K Buy
16,454
+382
+2% +$695 ﹤0.01% 2358
2025
Q4 		$37.8K Buy
+16,072
New +$30.9K ﹤0.01% 2353
2020
Q2 		– Sell
-1
Closed -$2K – 3043
2020
Q1 		$2K Buy
+1
New +$4.32K ﹤0.01% 3659
2019
Q4 		– Hold
0
– – – 3073
2019
Q3 		– Hold
0
– – – 3779

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Victory Capital Management's PALI Position: Q1 2026 in Review

Victory Capital Management increased its Palisade Bio (PALI) stake by 2.4% in Q1 2026, buying an estimated $695 and bringing the position to 16,454 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2358.

Victory Capital Management first reported a position in PALI in Q1 2020 and has held it in 3 quarters since. The position peaked at $37.8K in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Victory Capital Management held 16,454 shares of Palisade Bio worth $28.8K as of Q1 2026.
  • Victory Capital Management bought 382 Palisade Bio shares in Q1 2026, an estimated $695.
  • Palisade Bio made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2358 holding.
  • Victory Capital Management first reported a position in Palisade Bio in Q1 2020 and has held it in 3 quarters since.
  • Victory Capital Management's Palisade Bio position peaked at $37.8K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.